NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Old Version 1

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

compared with

New Version 2

changes.mady.by.user Frost, Ruth (NIH/NCI) [C]

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Replaced contents of table cell with Include Page macro pointing to include page with same contents.
FieldDescription
Submission Type

Indicates whether the trial is an original submission, an update, or an amendment.

NCI ID
Identifier assigned to the trial by the CTRP.

Include Page
Trial Attribute NCI ID - Include v4.4
Trial Attribute NCI ID - Include v4.4

Info
titleNCI Trial Identifiers

The prefix "NCI" is implicit in the NCI trial identifiers.

ClinicalTrials.gov Identifier
Identifier assigned to the trial by the National Clinical Trial program (ClinicalTrials.gov). Trials with this number have been submitted to ClinicalTrials.gov previously.

Include Page
Trial Attribute NCT ID - Include v4.4
Trial Attribute NCT ID - Include v4.4

CTEP IDIdentifies trials submitted by CTEP (Clinical Therapy Evaluation Program).
DCP ID

Identifies trials submitted by DCP (Division of Cancer Prevention).

CDR ID (PDQ ID)

Number assigned to trials in the Clinical Data Repository.

Submitting Organization

Organization that submitted the trial to CTRP.

Submission Date

Date on which the organization submitted the trial.

Amendment #

If the trial submitter has amended the trial, this number indicates the number of submissions.

Trial Category
Data Table 4 trial submission category, either Complete (National, Externally Peer-Reviewed, or Institutional trials), or Abbreviated (Industrial trials).

Include Page
Trial Attribute Study Source Category - Include v4.4
Trial Attribute Study Source Category - Include v4.4

Trial Type

Indicates whether the trial is Interventional or Observational.

Data Table 4 Funding
Indicates the funding source (Data Table 4 Funding Category). Values are: National, Externally Peer-Reviewed, Institutional, and Industrial/Other.

Include Page
Trial Attribute Study Source DT4 Funding - Include v4.4
Trial Attribute Study Source DT4 Funding - Include v4.4

On Hold Date

Date on which the abstractor put the trial on hold, if applicable.

Off Hold Date

Date on which the abstractor took the trial off hold, if applicable.

On Hold Reason

Include Page

Reason why the abstractor put the trial on hold, if applicable.

Trial Attribute Hold Reason - Include v4.4
Trial Attribute Hold Reason - Include v4.4

NCI Sponsored?

Indicates whether or not NCI sponsored the trial.

Assigned To

Displays the name of the user assigned to the trial by a Super Abstractor.

Submission SourceThe means by which the trial was submitted to the CTRP:
  • Batch: Trials submitted via the NCI CTRP Registration Batch Upload site
  • ClinicalTrials.gov: Trials imported from ClinicalTrials.gov
  • Grid Service: Trials submitted via the NCI CTRP web services
  • PDQ: Trials submitted via the NCI Physician Data Query database
  • Registry: Trials submitted via Registration
  • REST Service: Trials submitted via NCI CTRP Registration REST Service
  • Other: Trials submitted via any method other than those listed above
Processing Priority

Indicates the importance assigned to the trial by a Super Abstractor:

  • 1 = High
  • 2 = Normal
  • 3 = Low
Trial Processing Comments

Displays comments that an abstractor may have recorded previously, and enables you to enter new comments about the trial. (Limited to 4000 characters.)

Processing Status

Include Page
Trial Attribute Current Trial Processing Status

Relative stage of the trial processing workflow.

- Include v4.4
Trial Attribute Current Trial Processing Status - Include v4.4

Processing Status Date

Date on which the processing status was recorded.

Admin Check-out

Abstractor who has the trial checked out currently (if applicable).

Scientific Check-out

Scientific Abstractor who has the trial checked out currently (if applicable).

Milestone (table)

Lists milestones recorded to date.